Renal Cell Carcinoma Texture Analysis With the KiTS23 Dataset: A Retrospective Study
Advances in Urology · 2026-01 · 2026 (1)
DOI: 10.1155/aiu/5082571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Urology, online erschienen am 19.08.2026. Verfasst von Yuan Liang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science, University College Dublin, Dublin, Ireland, ucd.ie. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
Background and Aims Computed tomography texture analysis, powered by machine learning techniques, may differentiate clear cell renal cell carcinoma (ccRCC) from other renal tumor subtypes, such as papillary and chromophobe variants, or benign renal masses such as oncocytomas, as demonstrated here using the KiTS23 dataset.
Methods
After excluding multifocal cases to avoid lesion‐level labeling ambiguity and intrapatient lesion heterogeneity, 396 cases were included. Using PyRadiomics, 386 radiomics features were initially extracted from preprocessed computed tomography volumes and tumor segmentation masks. Subsequent multistage feature selection reduced the candidate feature set to 73 radiomics descriptors, and LASSO further selected six features for the primary classifier. Candidate machine‐learning models were evaluated, with class‐weighted Logistic Regression selected as the primary model. Threshold adjustment using the Youden index and bootstrap feature‐selection stability analysis were performed.
Results
The LASSO‐selected class‐weighted Logistic Regression model showed the best overall performance. Using the default probability threshold of 0.5, it achieved an accuracy of 76.5%, an area under the receiver operating characteristic curve of 80.4%, a precision of 91.2%, a sensitivity of 73.8%, and a specificity of 82.9% on the held‐out test set. Youden‐index thresholding increased sensitivity but reduced specificity; therefore, the fixed threshold of 0.5 was retained as the primary operating threshold. Bootstrap stability analysis showed that several LASSO‐selected radiomics descriptors were repeatedly selected across resampled training cohorts.
Conclusions
Radiomics‐based machine learning shows promise for discriminating ccRCC from non‐ccRCC renal tumors, but the results remain preliminary and have been evaluated internally. Given the moderate discrimination and lack of external validation, further studies using larger, multicenter datasets with standardized radiomics workflows are necessary.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Computer Science, University College Dublin, Dublin, Ireland, ucd.ie.
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin, Ireland, ucd.ie.
- Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland, ucd.ie.
- UCD One Health Centre, University College Dublin, Belfield, Dublin, Ireland, ucd.ie.
- UCD Earth Institute, University College Dublin, Belfield, Dublin, Ireland, ucd.ie.
- Institute for Functional Anatomy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte Philippstraße 11, Berlin 10115, Germany, charite.de.
ORCID-Profile: Yuan Liang, Abraham G Campbell, Sourav Bhattacharjee
Förderung
- China Scholarship Council
Zitieren
APA
Liang, Y., Campbell, A. G., & Bhattacharjee, S. (2026). Renal Cell Carcinoma Texture Analysis With the KiTS23 Dataset: A Retrospective Study. Advances in Urology, 2026(1). https://doi.org/10.1155/aiu/5082571
Vancouver
Liang Y, Campbell AG, Bhattacharjee S. Renal Cell Carcinoma Texture Analysis With the KiTS23 Dataset: A Retrospective Study. Advances in Urology. 2026;2026(1). doi:10.1155/aiu/5082571
BibTeX
@article{Liang2026,
author = {Liang, Yuan and Campbell, Abraham G and Bhattacharjee, Sourav},
title = {Renal Cell Carcinoma Texture Analysis With the KiTS23 Dataset: A Retrospective Study},
journal = {Advances in Urology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/aiu/5082571}
}
EUVIMED